Training program focused on cancer, DNA repair, and epigenetics.
Epigenetics, DNA repair and Genomics (EDGe) Training Program in Cancer
['FUNDING_TRAINING'] · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · NIH-10782813
This program is designed to help students learn about cancer, focusing on how DNA repair and changes in gene activity can affect cancer development, so they can work together with experienced mentors to find new ways to treat the disease.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER (nih funded) |
| Locations | 1 site (SAN ANTONIO, UNITED STATES) |
| Trial ID | NIH-10782813 on ClinicalTrials.gov |
What this research studies
This program aims to train pre-doctoral students in the fields of cancer biology, DNA repair, and epigenetics. It offers interdisciplinary training opportunities by connecting students with experienced faculty mentors and a curriculum that covers essential topics in cancer research. Students will engage in collaborative learning and research that explores the relationship between DNA repair mechanisms and epigenetic changes in cancer development. The program emphasizes the importance of understanding these processes to identify potential therapeutic strategies for cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are pre-doctoral students interested in cancer biology and related fields.
Not a fit: Patients who are not pursuing academic or research careers in cancer biology may not receive direct benefits from this program.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for various cancers.
How similar studies have performed: Similar interdisciplinary training programs have shown success in advancing cancer research and education.
Where this research is happening
SAN ANTONIO, UNITED STATES
- UNIVERSITY OF TEXAS HLTH SCIENCE CENTER — SAN ANTONIO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MALKOVA, ANNA L — UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
- Study coordinator: MALKOVA, ANNA L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer